Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

MLA

Giaccone, Giuseppe, et al. “Gefitinib in Combination with Gemcitabine and Cisplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial--INTACT 1.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 22, no. 5, Mar. 2004, pp. 777–84. EBSCOhost, https://doi.org/10.1200/JCO.2004.08.001.

APA

Giaccone, G., Herbst, R. S., Manegold, C., Scagliotti, G., Rosell, R., Miller, V., Natale, R. B., Schiller, J. H., Von Pawel, J., Pluzanska, A., Gatzemeier, U., Grous, J., Ochs, J. S., Averbuch, S. D., Wolf, M. K., Rennie, P., Fandi, A., & Johnson, D. H. (2004). Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 22(5), 777–784. https://doi.org/10.1200/JCO.2004.08.001

Chicago

Giaccone, Giuseppe, Roy S Herbst, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Vincent Miller, Ronald B Natale, et al. 2004. “Gefitinib in Combination with Gemcitabine and Cisplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial--INTACT 1.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 22 (5): 777–84. doi:10.1200/JCO.2004.08.001.